2025
SJR Q1
JCR Q2 · 3
806 matched articles
SCIE
Journal detail
Multiple Sclerosis and Related Disorders
- Publisher
- Elsevier B.V.
- Country
- Netherlands · Western Europe
- Type
- journal
- ISSN
-
2211034822110356
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,959
- Quartile Q1
- H-Index 77
- Cites/doc 2,82
- Docs (3y) 1.777
- Cites (3y) 5.089
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 3
- 5Y JIF 3,1
- JCI 0,81
WoS indexes
- SCIE
Subject classification
Categories (SJR)
Areas
WoS categories
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q2 | 0,959 | 3 | 3,1 | 0,81 | Q2 | 77 |
| 2024 | Q1 | Q2 | 1,05 | 2,9 | 3,1 | 0,88 | Q2 | 70 |
| 2023 | Q1 | Q2 | 0,99 | 2,9 | 3,2 | 0,94 | Q2 | 70 |
| 2022 | Q1 | Q2 | 0,92 | 4 | 3,9 | 0,96 | Q2 | 70 |
| 2021 | Q1 | Q2 | 1,006 | 4,8 | 4,6 | 0,97 | Q2 | 70 |
| 2020 | Q2 | Q2 | 0,87 | 4,3 | 4,3 | 0,97 | Q2 | 70 |
| 2019 | Q2 | Q2 | 0,829 | 2,9 | 3 | 0,84 | Q2 | 70 |
| 2018 | — | Q2 | — | 2,7 | 2,8 | 0,87 | Q2 | — |
| 2017 | Q1 | Q2 | 1,123 | 3,2 | 3 | 0,85 | Q2 | 70 |
| 2016 | Q1 | Q3 | 0,961 | 2,3 | 2,1 | — | — | 70 |
| 2015 | Q2 | Q4 | 0,624 | 1,1 | 1,2 | — | — | 70 |
| 2014 | Q2 | Q4 | 0,511 | 0,9 | 0,9 | — | — | 70 |
| 2013 | Q3 | — | 0,333 | — | — | — | — | 70 |
| 2012 | — | — | — | — | — | — | — | 70 |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | CLINICAL NEUROLOGY | SCIE | Q2 | Q2 | 133/296 |
| 2024 | CLINICAL NEUROLOGY | SCIE | Q2 | Q2 | 113/286 |
| 2023 | CLINICAL NEUROLOGY | SCIE | Q2 | Q2 | 102/280 |
| 2022 | CLINICAL NEUROLOGY | SCIE | Q2 | Q2 | 69/212 |
| 2021 | CLINICAL NEUROLOGY | SCIE | Q2 | Q2 | 64/212 |
| 2020 | CLINICAL NEUROLOGY | SCIE | Q2 | Q2 | 62/208 |
| 2019 | CLINICAL NEUROLOGY | SCIE | Q2 | Q2 | 92/204 |
| 2018 | CLINICAL NEUROLOGY | SCIE | Q2 | Q2 | 94/199 |
| 2017 | CLINICAL NEUROLOGY | SCIE | Q2 | Q2 | 70/197 |
| 2016 | CLINICAL NEUROLOGY | SCIE | Q3 | — | 104/194 |
| 2015 | CLINICAL NEUROLOGY | SCIE | Q4 | — | 162/193 |
| 2014 | CLINICAL NEUROLOGY | SCIE | Q4 | — | 168/192 |